ANABIN

ANABIN Tablets are a pharmaceutical formulation containing Paracetamol 325 mg and Caffeine 25 mg per tablet. Presented as an analgesic and antipyretic formulation, ANABIN combines two established pharmaceutical ingredients in a convenient oral tablet dosage form. The product is suitable for inclusion in pharmaceutical product catalogues serving hospitals, pharmacies, healthcare institutions and medical professionals.

Paracetamol, also known as acetaminophen, is the primary active ingredient, while caffeine is included as the second component of this fixed-combination formulation. Each tablet contains the specified strengths of both ingredients, making accurate product identification and composition details important for pharmaceutical procurement and inventory management.

ANABIN Tablets are supplied in a pack containing 30 strips of 10 tablets each. This presentation supports straightforward product identification, stock handling and pack-level inventory recording. The product listing includes its brand name, active ingredients, strengths, dosage form and packaging configuration to assist healthcare procurement teams and pharmacy distributors in maintaining accurate product records.